Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling.

Source:http://linkedlifedata.com/resource/pubmed/id/10600134

Biochemistry 1999 Dec 14 38 50 16706-13

Download in:

View as

General Info

PMID
10600134